Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Immuneering A | IMRX | Mar 17, 2025 | 1.68 | +5.00 |
Immunic | IMUX | Mar 17, 2025 | 1.14 | -0.87 |
ImmunityBio | IBRX | Mar 17, 2025 | 2.91 | +1.39 |
Immunocore ADR | IMCR | Mar 17, 2025 | 30.04 | +4.31 |
Immunome | IMNM | Mar 17, 2025 | 9.04 | +3.08 |
ImmunoPrecise Antibodies | IPA | Mar 17, 2025 | 0.43 | +11.46 |
Immunovant | IMVT | Mar 17, 2025 | 20.02 | +2.56 |
Immutep ADR | IMMP | Mar 17, 2025 | 1.82 | +2.25 |
Imperial Oil | IMO | Mar 17, 2025 | 69.15 | +1.84 |
Imperial Petroleum | IMPP | Mar 17, 2025 | 2.50 | +1.63 |
Imperial Petroleum A Pref | IMPPP | Mar 17, 2025 | 24.86 | +0.65 |
Impinj | PI | Mar 17, 2025 | 92.73 | +2.65 |
Imunon | IMNN | Mar 17, 2025 | 0.89 | +2.88 |
IN8bio | INAB | Mar 17, 2025 | 0.23 | +0.35 |
Inari Medical | NARI | Mar 17, 2025 | 79.97 | 0.00 |
Incannex Healthcare ADR | IXHL | Mar 17, 2025 | 0.74 | 0.00 |
Income Opportunity Realty Investors | IOR | Mar 17, 2025 | 17.35 | -2.25 |
Incyte | INCY | Mar 17, 2025 | 62.01 | -8.62 |
Indaptus Therapeutics | INDP | Mar 17, 2025 | 0.81 | +0.89 |
Independence Realty Trust | IRT | Mar 17, 2025 | 21.00 | +0.10 |
Independent Bank | IBCP | Mar 17, 2025 | 31.00 | +0.29 |
Independent Bank | INDB | Mar 17, 2025 | 64.13 | +0.74 |
India Bull 3X Direxion | INDL | Mar 17, 2025 | 51.60 | +2.30 |
India Consumer Egshares | INCO | Mar 17, 2025 | 57.38 | +0.53 |
India Earnings Wisdomtree | EPI | Mar 17, 2025 | 41.83 | +0.97 |
India Fund | IFN | Mar 17, 2025 | 15.13 | +1.68 |
India Powershares | PIN | Mar 17, 2025 | 24.14 | +1.33 |
Indie Semiconductor A | INDI | Mar 17, 2025 | 2.49 | +6.41 |
Indivior | INDV | Mar 17, 2025 | 9.99 | +3.20 |
Indonesia Energy | INDO | Mar 17, 2025 | 2.90 | +7.41 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.